cefazolin has been researched along with oxacillin in 51 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 12 (23.53) | 18.7374 |
1990's | 9 (17.65) | 18.2507 |
2000's | 11 (21.57) | 29.6817 |
2010's | 14 (27.45) | 24.3611 |
2020's | 5 (9.80) | 2.80 |
Authors | Studies |
---|---|
Biegel, A; Brandsch, M; Gebauer, S; Hartrodt, B; Neubert, K; Thondorf, I | 1 |
Amblard, M; Bastide, L; Gualtieri, M; Leonetti, JP; Martinez, J; Pugniere, M; Roquet, F; Villain-Guillot, P | 1 |
Higashide, M; Ichimura, S; Kumano, M; Kuroda, M; Ohkawa, S; Ohta, T; Omura, CT | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Arakawa, Y; Kato, H; Kimura, K; Kurokawa, H; Nagano, N; Shibata, N; Shibayama, K; Suzuki, S; Wachino, J; Yamane, K | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Anderson, KC; Kellogg, GE; Sarkar, A | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Bivins, B; DeLuca, PP; Rapp, R; Rebagay, T | 1 |
Klastersky, J; Levy, J | 1 |
Lautenschlager, EP; Marks, KE; Nelson, CL | 1 |
Brust, JC; Lenchner, GS; Messer, HD; Resor, S | 1 |
Cattani, C; Merli, M; Pellegrini, A; Pratelli, EM | 1 |
Betka, J; Taudy, M | 1 |
Crokaert, F; van der Linden, MP; Yourassowsky, E | 1 |
Guay, D; Klicker, R; Pence, T; Peterson, P | 1 |
Jackson, CG | 1 |
Axelrod, JL; Bergen, RL; Klein, RM; Sheikh, MZ | 1 |
Watanakunakorn, C | 1 |
Bartlett, RC; Marcon, MJ | 1 |
Barza, M; Baum, J; Kane, A | 1 |
Belcher, C; Foster, CS; Haaf, J; Lass, JH | 1 |
Hahn, JF; Kalfas, IH; Murphy, MA; Rhoten, RL; Washington, JA | 1 |
Hu, BS; Lau, YJ; Lin, YH; Liu, PY; Shi, ZY; Shyr, JM; Tsai, WS; Tseng, CY | 1 |
Classen, DC; Kaiser, AB; Kernodle, DS; Stratton, CW | 1 |
Igari, J; Nakamura, A; Oguri, T; Tabe, Y | 1 |
Carsenti-Etesse, H; Dellamonica, P; Desplaces, N; Doyon, F; Dunais, B; Gagey, O; Pradier, C; Tancrède, C | 1 |
Carsenti-Etesse, H; Dellamonica, P; Desplaces, N; Doyon, F; Evrard, J; Gagey, O; Tancrède, C | 1 |
Barriere, SL; Dunn, DL; Graham, DR; Kreter, B; Nichols, RL; Rodgers, A; Wilson, SE; Zervos, M | 1 |
Cirioni, O; Ghiselli, R; Giacometti, A; Mocchegiani, F; Riva, A; Saba, V; Scalise, G | 1 |
Arnold, FW; Wojda, B | 1 |
Dalovisio, JR; Jiang, X; Tice, AD; Wynn, M | 1 |
Cai, Y; Liang, BB; Pei, F; Wang, R | 1 |
Bloem, RM; Buma, P; Mathijssen, NM; Petit, PL; Pilot, P; Schreurs, BW | 1 |
Barretti, P; Caramori, JC; Cunha, Mde L; Luengo, J; Montelli, AC; Oliveira, LG | 1 |
Chan, YS; Chang, Y; Hsieh, PH; Lee, MS; Shih, HN; Ueng, SW | 1 |
Bowling, JE; Cadena, JA; Echevarria, KL; Hughes, DW; Lewis, JS; Li, J | 1 |
Valour, F | 1 |
Crank, CW; Hanson, AP; Lee, BJ; Rao, SN; Rhodes, NJ; Scheetz, MH; Segreti, J; Wang, SK | 1 |
Hulin, A; Khoudour, N; Legrand, T; Tournier, N; Vodovar, D | 1 |
Barr, VO; Bolon, M; Gilbert, EM; Lakada, IY; Lee, BJ; Lee, JY; Postelnick, MJ; Rao, SN; Rhodes, NJ; Scheetz, MH; Sutton, SH; Wang, SK; Zembower, TR | 1 |
Karchmer, AW | 1 |
Baracco, G; Carrasquillo, M; Gauthier, TP; Lichtenberger, P | 1 |
Alshehri, S; Eljaaly, K; Erstad, BL | 1 |
Boyle, KK; Frisch, NB; Nodzo, SR | 1 |
Bayer, AS; Chambers, HF; Chen, L; Ersoy, SC; Fowler, VG; Kreiswirth, B; Li, L; Mediavilla, J; Milan, VT; Otmishi, M; Pak, Y; Proctor, RA; Xiong, YQ | 1 |
Carter, GP; Ferguson, JK; Henderson, A; Lacey, JA; Marr, I; Swe, K | 1 |
Dilworth, T; Hernandez, BN; Kesner, J; Mercier, RC; Ryan, K; Thelen, H | 1 |
Chen, H; Dai, L; Hou, D; Li, T; Long, X; Sun, C; Wang, Y; Xiong, Z | 1 |
DeSimone, DC; Fida, M; Go, JR; Hess, KA; Kooda, K; Mara, K; Shulha, JA; Stevens, RW | 1 |
2 review(s) available for cefazolin and oxacillin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Systematic Review and Meta-analysis of the Safety of Antistaphylococcal Penicillins Compared to Cefazolin.
Topics: Anti-Bacterial Agents; Cefazolin; Odds Ratio; Oxacillin; Penicillins; Staphylococcus aureus | 2018 |
4 trial(s) available for cefazolin and oxacillin
Article | Year |
---|---|
Epidemiology of bacterial infection during management of open leg fractures.
Topics: 4-Quinolones; Adolescent; Adult; Anti-Infective Agents; Antibiotic Prophylaxis; Cefazolin; Cephalosporins; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Fluoroquinolones; Fractures, Open; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Leg Injuries; Methicillin Resistance; Oxacillin; Pefloxacin; Penicillins; Surgical Wound Infection | 1999 |
[Infection prophylaxis in open leg fractures. Comparison of a dose of pefloxacin and 5 days of cefazolin-oxacillin. A randomized study of 616 cases].
Topics: Adult; Anti-Infective Agents; Antibiotic Prophylaxis; Cefazolin; Cephalosporins; Double-Blind Method; Female; Humans; Male; Middle Aged; Oxacillin; Pefloxacin; Penicillins; Risk Factors; Surgical Wound Infection; Tibial Fractures; Time Factors; Wound Infection | 1999 |
Treatment of hospitalized patients with complicated gram-positive skin and skin structure infections: two randomized, multicentre studies of quinupristin/dalfopristin versus cefazolin, oxacillin or vancomycin. Synercid Skin and Skin Structure Infection Gr
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Cefazolin; Cephalosporins; Female; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Hospitalization; Humans; Male; Middle Aged; Oxacillin; Penicillins; Skin Diseases, Bacterial; Vancomycin; Virginiamycin | 1999 |
Cefazolin susceptibility of coagulase-negative staphylococci (CoNS) causing late-onset neonatal bacteraemia.
Topics: Anti-Bacterial Agents; Australia; Bacteremia; Cefazolin; Coagulase; Humans; Infant, Newborn; Microbial Sensitivity Tests; Oxacillin; Staphylococcal Infections | 2022 |
45 other study(ies) available for cefazolin and oxacillin
Article | Year |
---|---|
Three-dimensional quantitative structure-activity relationship analyses of beta-lactam antibiotics and tripeptides as substrates of the mammalian H+/peptide cotransporter PEPT1.
Topics: Animals; beta-Lactams; Cell Line, Tumor; Dipeptides; Drug Design; Humans; Mammals; Models, Molecular; Oligopeptides; Peptide Transporter 1; Quantitative Structure-Activity Relationship; Substrate Specificity; Symporters | 2005 |
Structure-activity relationships of phenyl-furanyl-rhodanines as inhibitors of RNA polymerase with antibacterial activity on biofilms.
Topics: Animals; Anti-Bacterial Agents; Biofilms; CHO Cells; Cricetinae; Cricetulus; DNA-Directed RNA Polymerases; Furans; Gram-Positive Bacteria; Microbial Sensitivity Tests; Rhodanine; Staphylococcus epidermidis; Structure-Activity Relationship | 2007 |
Methicillin-resistant Staphylococcus saprophyticus isolates carrying staphylococcal cassette chromosome mec have emerged in urogenital tract infections.
Topics: Bacterial Proteins; Chromosomes, Bacterial; Electrophoresis, Gel, Pulsed-Field; Methicillin Resistance; Molecular Sequence Data; Polymerase Chain Reaction; Sequence Analysis, DNA; Staphylococcal Infections; Staphylococcus; Urinary Tract Infections | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
First molecular characterization of group B streptococci with reduced penicillin susceptibility.
Topics: Amino Acid Sequence; Amino Acid Substitution; Ampicillin; Anti-Bacterial Agents; Bacterial Proteins; Blotting, Western; Cefepime; Cefotaxime; Ceftizoxime; Cephalosporins; Electrophoresis, Gel, Pulsed-Field; Humans; Japan; Microbial Sensitivity Tests; Molecular Sequence Data; Oxacillin; Penicillin Resistance; Penicillin-Binding Proteins; Penicillins; Sequence Analysis, DNA; Sequence Homology, Amino Acid; Streptococcal Infections; Streptococcus agalactiae | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Computational analysis of structure-based interactions and ligand properties can predict efflux effects on antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactams; Computational Biology; Drug Resistance, Bacterial; Hydrophobic and Hydrophilic Interactions; Ligands; Membrane Transport Proteins; Microbial Sensitivity Tests; Models, Molecular; Protein Binding; Protein Conformation; Quantitative Structure-Activity Relationship; Regression Analysis; Thermodynamics | 2012 |
Residues in antibiotic preparations, i: scanning electron microscopic studies of surface topography.
Topics: Amphotericin B; Ampicillin; Anti-Bacterial Agents; Carbenicillin; Cefazolin; Cephaloridine; Cephalothin; Drug Contamination; Filtration; Hydrogen-Ion Concentration; Kanamycin; Methicillin; Microscopy, Electron, Scanning; Nafcillin; Oxacillin; Oxytetracycline; Penicillin G; Tetracycline | 1976 |
Synergism between amikacin and cefazolin against Staphylococcus aureus: a comparative study of oxacillin-sensitive and oxacillin-resistant strains.
Topics: Amikacin; Cefazolin; Drug Synergism; Humans; Kanamycin; Male; Oxacillin; Penicillin Resistance; Staphylococcus aureus; Time Factors | 1979 |
Antibiotic-impregnated acrylic bone cement.
Topics: Animals; Anti-Bacterial Agents; Bacillus; Bacterial Infections; Biomechanical Phenomena; Bone Cements; Bone Diseases; Cefazolin; Dogs; Escherichia coli Infections; Gentamicins; Humans; Methylmethacrylates; Oxacillin; Pseudomonas Infections; Staphylococcal Infections | 1976 |
Lumbar spinal abscess managed conservatively. Case report.
Topics: Abscess; Anti-Bacterial Agents; Cefazolin; Cocaine; Duodenal Ulcer; Heroin; Humans; Kidney Failure, Chronic; Male; Meninges; Methicillin; Middle Aged; Myelography; Oxacillin; Renal Dialysis; Spinal Cord Diseases; Staphylococcal Infections; Staphylococcus aureus; Subdural Space; Substance-Related Disorders | 1977 |
[Antibiotic prophylaxis in heart surgery. 3 years experience].
Topics: Bacterial Infections; Cardiac Surgical Procedures; Cefazolin; Humans; Klebsiella Infections; Oxacillin; Postoperative Complications | 1975 |
[Personal experience with antibiotic prophylaxis in extensive otorhinolaryngologic procedures].
Topics: Ampicillin; Anti-Bacterial Agents; Bacterial Infections; Cefazolin; Clindamycin; Humans; Otorhinolaryngologic Diseases; Oxacillin; Postoperative Complications; Premedication | 1990 |
Inoculum effect on growth-delay time of oxacillin-resistant strains of Staphylococcus aureus and Staphylococcus epidermidis exposed to cefamandole, cefazolin, and cefuroxime.
Topics: Cefamandole; Cefazolin; Cefuroxime; Cephalosporins; Oxacillin; Penicillin Resistance; Phenotype; Staphylococcus aureus; Staphylococcus epidermidis; Time Factors | 1990 |
In vitro antistaphylococcal activity of teicoplanin and ciprofloxacin in peritoneal dialysis effluent.
Topics: Anti-Bacterial Agents; Ascitic Fluid; Cefazolin; Ciprofloxacin; Glycopeptides; Humans; Oxacillin; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Staphylococcal Infections; Staphylococcus; Staphylococcus epidermidis; Teicoplanin; Vancomycin | 1986 |
Antimicrobial prophylaxis in ear surgery.
Topics: Adult; Anti-Bacterial Agents; Cefazolin; Cephalothin; Child; Data Interpretation, Statistical; Ear; Female; Graft Survival; Humans; Male; Oxacillin; Premedication; Prospective Studies; Surgical Wound Infection; Vancomycin | 1988 |
Human vitreous levels of selected antistaphylococcal antibiotics.
Topics: Anti-Bacterial Agents; Cefazolin; Cephalothin; Endophthalmitis; Humans; Injections, Intravenous; Methicillin; Nafcillin; Oxacillin; Staphylococcal Infections; Vitreous Body | 1985 |
Antibiotic tolerance of Staphylococcus epidermidis.
Topics: Anti-Bacterial Agents; Cefazolin; Cephalothin; Drug Tolerance; Methicillin; Microbial Sensitivity Tests; Nafcillin; Oxacillin; Staphylococcus epidermidis; Vancomycin | 1985 |
Laboratory evaluation of the serum dilution test in serious staphylococcal infection.
Topics: Anti-Bacterial Agents; Biological Availability; Cefazolin; Cephalexin; Culture Media; Dicloxacillin; Evaluation Studies as Topic; Humans; Oxacillin; Penicillin Resistance; Protein Binding; Serologic Tests; Staphylococcal Infections; Staphylococcus aureus | 1983 |
Ocular penetration of subconjunctival oxacillin, methicillin, and cefazolin in rabbits with staphylococcal endophthalmitis.
Topics: Animals; Anti-Bacterial Agents; Aqueous Humor; Cefazolin; Conjunctiva; Cornea; Endophthalmitis; Eye; Kinetics; Methicillin; Oxacillin; Rabbits; Retina; Sclera; Staphylococcal Infections; Vitreous Body | 1982 |
Visual outcome in eight cases of Serratia marcescens keratitis.
Topics: Aged; Bacitracin; Carbenicillin; Cefazolin; Conjunctiva; Contact Lenses; Corneal Ulcer; Female; Gentamicins; Humans; Keratitis; Male; Middle Aged; Oxacillin; Serratia marcescens; Surgical Flaps | 1981 |
Antibiotic penetration into cervical discs.
Topics: Adult; Aged; Aged, 80 and over; Antibiotic Prophylaxis; Biological Availability; Cefazolin; Cephalosporins; Cervical Vertebrae; Diskectomy; Female; Humans; Intervertebral Disc; Male; Metabolic Clearance Rate; Middle Aged; Oxacillin; Penicillins; Spinal Fusion | 1995 |
Endogenous endophthalmitis due to Escherichia coli: case report and review.
Topics: Anti-Bacterial Agents; Cefazolin; Cefotaxime; Emphysema; Endocarditis; Endophthalmitis; Escherichia coli Infections; Fatal Outcome; Gentamicins; Humans; Male; Middle Aged; Oxacillin; Sepsis; Urinary Tract Infections | 1996 |
Association of borderline oxacillin-susceptible strains of Staphylococcus aureus with surgical wound infections.
Topics: Cefazolin; Drug Resistance, Microbial; Microbial Sensitivity Tests; Oxacillin; Penicillins; Staphylococcus aureus; Surgical Wound Infection | 1998 |
Molecular characterization of epidemic multiresistant Staphylococcus haemolyticus isolates.
Topics: Ampicillin; Anti-Bacterial Agents; Cefazolin; Cefmetazole; Cross Infection; DNA Restriction Enzymes; Drug Resistance, Microbial; Drug Resistance, Multiple; Electrophoresis, Gel, Pulsed-Field; Gentamicins; Hospital Bed Capacity, 500 and over; Humans; Imipenem; Infant, Newborn; Microbial Sensitivity Tests; Neonatal Nursing; Nursing Staff, Hospital; Ofloxacin; Oxacillin; Phylogeny; Staphylococcal Infections; Staphylococcus; Tobramycin; Vancomycin | 1998 |
[Vascular graft infection by Staphylococcus epidermidis: efficacy of various perioperative prophylaxis protocols in an animal model].
Topics: Animals; Blood Vessel Prosthesis Implantation; Cefazolin; Drug Evaluation, Preclinical; Drug Implants; Drug Resistance; Drug Therapy, Combination; Injections, Intraperitoneal; Levofloxacin; Male; Methicillin Resistance; Models, Animal; Ofloxacin; Oxacillin; Premedication; Prostheses and Implants; Prosthesis-Related Infections; Rats; Rats, Wistar; Rifampin; Staphylococcal Infections; Staphylococcus epidermidis; Teicoplanin | 2001 |
An analysis of a community-acquired pathogen in a Kentucky community: methicillin-resistant Staphylococcus aureus.
Topics: Adult; Anti-Bacterial Agents; Cefazolin; Clindamycin; Community-Acquired Infections; Erythromycin; Female; Humans; Kentucky; Levofloxacin; Male; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Oxacillin; Rifampin; Risk Factors; Staphylococcal Infections; Staphylococcus aureus; Sulfamethoxazole; Tetracycline; Trimethoprim; Vancomycin | 2005 |
Evaluation of the efficacy and safety of outpatient parenteral antimicrobial therapy for infections with methicillin-sensitive Staphylococcus aureus.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefazolin; Ceftriaxone; Child; Child, Preschool; Clindamycin; Drug Monitoring; Female; Home Infusion Therapy; Humans; Infant; Infusions, Parenteral; Male; Middle Aged; Nafcillin; Oxacillin; Retrospective Studies; Streptococcal Infections; Treatment Outcome; Vancomycin | 2005 |
Antibacterial activity of allicin alone and in combination with beta-lactams against Staphylococcus spp. and Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefazolin; Cefoperazone; Disulfides; Drug Synergism; Microbial Sensitivity Tests; Oxacillin; Pseudomonas aeruginosa; Staphylococcus; Sulfinic Acids | 2007 |
Impregnation of bone chips with antibiotics and storage of antibiotics at different temperatures: an in vitro study.
Topics: Acetamides; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bone Transplantation; Cefazolin; Clindamycin; Dose-Response Relationship, Drug; Drug Compounding; Drug Stability; Drug Storage; Humans; Linezolid; Microbial Sensitivity Tests; Oxacillin; Oxazolidinones; Prosthesis-Related Infections; Staphylococcus epidermidis; Surgical Wound Infection; Temperature; Transplantation, Homologous; Vancomycin | 2010 |
Peritonitis in recent years: clinical findings and predictors of treatment response of 170 episodes at a single Brazilian center.
Topics: Age Factors; Aged; Amikacin; Anti-Bacterial Agents; Brazil; Cefazolin; Ceftazidime; Drug Resistance, Bacterial; Enterobacteriaceae Infections; Enterococcus; Female; Humans; Male; Middle Aged; Multivariate Analysis; Oxacillin; Peritoneal Dialysis; Peritonitis; Recurrence; Staphylococcal Infections; Streptococcal Infections; Survival Analysis; Treatment Outcome; Vancomycin | 2012 |
Antibacterial activity of joint fluid in cemented total-knee arthroplasty: an in vivo comparative study of polymethylmethacrylate with and without antibiotic loading.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Arthroplasty, Replacement, Knee; Cefazolin; Cementation; Chromatography, High Pressure Liquid; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Oxacillin; Polymethyl Methacrylate; Staphylococcal Infections; Synovial Fluid; Vancomycin | 2012 |
Comparison of cefazolin versus oxacillin for treatment of complicated bacteremia caused by methicillin-susceptible Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Bacteremia; Cefazolin; Female; Humans; Male; Methicillin; Microbial Sensitivity Tests; Middle Aged; Oxacillin; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus | 2014 |
[Cefazolin: a well-tolerated treatment for methicillin-susceptible Staphylococcus aureus complicated bacteremia].
Topics: Anti-Bacterial Agents; Bacteremia; Cefazolin; Female; Humans; Male; Methicillin; Oxacillin; Staphylococcus aureus | 2015 |
Treatment outcomes with cefazolin versus oxacillin for deep-seated methicillin-susceptible Staphylococcus aureus bloodstream infections.
Topics: Adult; Aged; Cefazolin; Cohort Studies; Female; Humans; Male; Methicillin; Middle Aged; Oxacillin; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome | 2015 |
Simultaneous Determination of Eight β-Lactam Antibiotics, Amoxicillin, Cefazolin, Cefepime, Cefotaxime, Ceftazidime, Cloxacillin, Oxacillin, and Piperacillin, in Human Plasma by Using Ultra-High-Performance Liquid Chromatography with Ultraviolet Detection
Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactams; Cefazolin; Cefepime; Cefotaxime; Ceftazidime; Cephalosporins; Chromatography, High Pressure Liquid; Cloxacillin; Drug Monitoring; Humans; Oxacillin; Piperacillin; Ultraviolet Rays | 2016 |
Implementation of a cefazolin-based stewardship pathway for methicillin-susceptible Staphylococcus aureus bloodstream infections paired with infectious diseases consultation.
Topics: Anti-Bacterial Agents; Antimicrobial Stewardship; Bacteremia; Cefazolin; Female; Hospital Mortality; Humans; Male; Methicillin; Middle Aged; Oxacillin; Staphylococcal Infections; Staphylococcus aureus | 2017 |
Definitive Treatment for Methicillin-Susceptible Staphylococcus aureus Bacteremia: Data Versus a Definitive Answer?
Topics: Bacteremia; Cefazolin; Cohort Studies; Humans; Methicillin; Nafcillin; Oxacillin; Staphylococcal Infections; Staphylococcus aureus | 2017 |
Economic Impact of a Preferred Anti-Methicillin Susceptible Staphylococcus aureus Protocol.
Topics: Bacteremia; Cefazolin; Cohort Studies; Humans; Methicillin; Nafcillin; Oxacillin; Staphylococcus aureus | 2018 |
Nationwide Organism Susceptibility Patterns to Common Preoperative Prophylactic Antibiotics: What Are We Covering?
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefazolin; Clindamycin; Data Collection; Humans; Methicillin; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxacillin; Prosthesis-Related Infections; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis; United States; Vancomycin | 2019 |
Scope and Predictive Genetic/Phenotypic Signatures of Bicarbonate (NaHCO
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Cefazolin; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxacillin; Phenotype; Predictive Value of Tests; Prevalence; Sodium Bicarbonate; Staphylococcal Infections | 2020 |
MIC Discrepancies between Parenteral and Oral Anti-Staphylococcal Beta-Lactams among MSSA.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefazolin; Cefoxitin; Cephalexin; Dicloxacillin; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Monobactams; Oxacillin; Staphylococcal Infections; Staphylococcus aureus | 2023 |
Pathogenicity and transcriptome analysis of a strain of Vibrio owensii in Fenneropenaeus merguiensis.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Aztreonam; Cefazolin; Cefotaxime; Ciprofloxacin; Citrates; Gene Expression Profiling; Immunity, Innate; Lectins, C-Type; Minocycline; Oxacillin; Penaeidae; Phosphatidylinositol 3-Kinases; Piperacillin; Proto-Oncogene Proteins c-akt; Pyruvates; Streptomycin; Transcriptome; Vibrio; Virulence | 2022 |
Retrospective Evaluation of the Association of Oxacillin MIC on Acute Treatment Outcomes with Cefazolin and Antistaphylococcal Penicillins in Methicillin-Susceptible Staphylococcus aureus Bacteremia.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Cefazolin; Humans; Methicillin; Oxacillin; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome | 2023 |